20902 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof; Peptides having 5 to 11 amino acids Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH] ; Related peptides
METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
#2Systems and methods of treating prostate cancer
#3AMNIOTIC FLUID COMPOSITION AND METHOD OF USING
#4POLYMERIC LEUPROLIDE ACETATE FORMULATIONS
#5COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
#6USE OF GNRH ANTAGONISTS IN MAMMALS TO SYNCHRONIZE FOLLICULAR WAVE EMERGENCE
#7LEUPROLIDE ACETATE COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT BREAST CANCER
#8IMPROVED ORAL PHARMACEUTICAL FORMULATIONS OF THERAPEUTIC PEPTIDES AND PROTEINS
#9DESLORELIN USE IN CHEMICAL CASTRATION OF A NON-HUMAN MAMMAL RELATED TO PK/PD INTERACTION
#10DESLORELIN FOR ATTENUATION OF ANIMAL URINE ODOR
#11PREPARATION METHOD OF LONG-ACTING SUSTAINED AND CONTROLLED RELEASE IMPLANT
#12SUSTAINED-RELEASE MICROPARTICLES CONTAINING DRUG AND PAMOIC ACID
#13GOSERELIN IMPLANT DOSING REGIMENS FOR IMPROVED PATIENT COMPLIANCE
#14PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#15METHODS OF TREATING DILATED CARDIOMYOPATHY AND HEART FAILURE
#16SEQUENTIAL HORMONE THERAPY TO IMPROVE SURVIVAL AND ENHANCE RESPONSE TO IMMUNE THERAPY IN MEN WITH PROSTATE CANCER
#17COMPOSITIONS AND METHODS FOR TREATING PRECOCIOUS PUBERTY
#18Implantable Device for Release of Gonadotropin-Releasing Hormone Agonist or Antagonist
#19TREATMENT OF WOMEN AFFECTED WITH POLYCYSTIC OVARY SYNDROME
#20METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
#21METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS
#22Method of Treating Hormonal Disorders Using Injectable Leuprolide
#23Pharmaceutical Compositions having a Selected Release Duration
#24OXAZAPHOSPHORINE ANTIBODY DRUG CONJUGATES AND METHODS OF USE
#25RAPIDLY DISSOLVING SALT TABLET COMPOSITIONS AND METHODS
#26METHODS OF MANUFACTURING INJECTABLE SUSTAINED RELEASE FORMULATIONS
#27METHODS AND COMPOSITIONS FOR REPRODUCTIVE MANAGEMENT OF SHEEP AND GOATS
#28COMPOSITION FOR SUSTAINED-RELEASE INJECTION COMPRISING DESLORELIN
#29READY TO USE COMPOSITIONS OF CETRORELIX ACETATE
#30NON-LAMELLAR LIQUID CRYSTAL-FORMING COMPOSITION AND USE THEREOF
#31METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
#32PHARMACEUTICAL KIT FOR PARENTERAL CO-ADMINISTRATION
#33GONADOTROPIN-RELEASING HORMONE ANTAGONIST DOSING REGIMENS FOR THE TREATMENT OF ENDOMETRIOSIS
#34L-FUCOSE AND ANTI-ANDROGEN RECEPTOR THERAPY FOR TREATMENT OF CANCER
#35MICRONEEDLES COMPRISING HORMONE-CONTAINING SURFACE-MODIFIED MICROSPHERES AND METHOD OF PREPARING THE SAME
#36LUTEINIZING HORMONE-RELEASING HORMONE RECEPTOR (LHRH-R) CONJUGATES AND USES THEREOF
#37Treatment of breast cancer using combination therapies comprising GDC-9545 and a CDK4/6 inhibitor
#38COMBINATORIAL ANDROGEN DEPRIVATION WITH AN ANDROGEN RECEPTOR VACCINE
#39COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
#40LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED ADMINISTRATION OF DRUGS
#41PULSATIVE GNRH ADMINISTRATION FOR TREATING FOOD INTAKE RELATED DISORDERS
#42IMMUNORHELIN COMPOUNDS FOR INTRACELLULAR INFECTIONS
#43Substituted benzothiophene analogs as selective estrogen receptor degraders
#44LYOPHILIZATION PROCESS AND A TEVERELIX-TFA LYOPHILIZATE OBTAINED THEREBY
#45METHOD OF DELIVERING GONADOTROPIN RELEASING HORMONE OR AN ANALOGUE THEREOF INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#46Pharmaceutical compositions having a selected release duration
#47CETRORELIX INJECTABLE LIQUID FORMULATION
#48RECONSTITUTABLE TEVERELIX-TFA COMPOSITION
#49NK RECEPTOR ANTAGONISTS FOR CANCER PATIENTS
#50COMPOSITION FOR SUSTAINED-RELEASE INJECTION COMPRISING DESLORELIN
#51INJECTABLE COMPOSITION COMPRISING GnRH ANALOGUE
#52TREATMENT WITH ANTI-VEGF ANTIBODIES
#53Increasing Cancer Patient Survival Time by Administration of Dithio-Containing Compounds
#54Microparticles containing leuprolide and method for producing the same
#55SYSTEMS AND METHODS OF TREATING PROSTATE CANCER
#56HIGHLY SAFE NON-LAMELLAR LIQUID CRYSTAL FORMING COMPOSITION
#57COMPOSITIONS FOR ENDOMETRIOSIS ASSESSMENT HAVING IMPROVED SPECIFICITY
#58PROGESTERONE FORMULATION TO TRIGGER OVULATION AND PROVIDE LUTEAL PHASE SUPPORT
#59COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES
#60Pharmaceutical compositions and related methods of delivery
#61Pharmaceutical compositions and related methods of delivery
#62TRANSDERMAL ABSORPTION-TYPE PATCH
#63Combination of An Agonist Anti-PD-1 Antibody With a GnRH Agonist or Antagonist to Treat Cancer
#64NON-INVASIVE EGG RETRIEVAL PROTOCOLS AND METHODS
#65AN IMMUNOTHERAPEUTIC FOR PROSTATE CANCER TREATMENT
#66METHODS FOR TREATING METASTATIC STAGE PROSTATE CANCER
#67Method of Treating a Child with Central Precocious Puberty using an Extended Release Composition
#68METHODS AND COMPOSITIONS FOR DETECTING AND TREATING ENDOMETRIOSIS
#69GNRH ANTAGONISTS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISORDERS
#70Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases
#71Teverelix-TFA composition
#72LEUPROLIDE ACETATE COMPOSITIONS AND METHODS OF USING THE SAME TO TREAT BREAST CANCER
#73Treatment of women affected with polycystic ovary syndrome
#74SUSTAINED-RELEASE MICROPARTICLES FOR SUSTAINED RELEASE OF DRUG
#75METHODS AND COMPOSITIONS FOR TREATING ANDROGEN RECEPTOR DEFICIENT, ANDROGEN RECEPTOR LOW, AND CASTRATION-RESISTANT PROSTATE CANCERS
#76STABLE FORMULATION OF CETRORELIX
#77AN AMNIOTIC FLUID COMPOSITION AND METHOD OF USING
#78Method of treating prostate cancer with GnRH antagonist
#79METHODS FOR TREATING METASTATIC STAGE PROSTATE CANCER
#80METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
#81PULSATIVE GNRH ADMINISTRATION FOR TREATING COGNITIVE DISORDERS
#82Sustained-release microparticles containing deslorelin, and preparation method therefor
#83Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
#84Pharmaceutical composition with improved stability
#85Compositions and Methods for increasing Reproduction Performance in Non Human Mammals Using Recombinant Luteinizing Hormone
#86Sustained-release lipid preformulation and pharmaceutical composition for sustained-release injection in form of lipid solution containing same
#87Substituted benzothiophene analogs as selective estrogen receptor degraders
#88Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (VSELs)
#89Agonists of Human Kisspeptin Receptor for Modulating Sexual Desire
#90TREATMENT OF PROSTATE CANCER BY ANDROGEN ABLATION AND IL-8 BLOCKADE
#91METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST
#92Sustained-release injection comprising deslorelin, and preparation method therefor
#93System and method for diagnosis and treatment
#94Treatment of breast cancer using combination therapies comprising GDC-9545 and a CDK4/6 inhibitor
#95SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION
#96Systems, methods, and kits for diagnostics and treatment of viral respiratory infection
#97Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof
#98METHOD OF MODULATING THE CONCENTRATION OF PROTEINS IN CEREBROSPINAL FLUID
#99Lyophilization process and a teverelix-TFA lyophilizate obtained thereby
#100Teverelix-TFA composition
#101Reconstitutable teverelix-TFA composition
#102COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#103Compounds and methods for the targeted degradation of androgen receptor
#104Androgen Receptor Modulator And Uses Thereof
#105Manufacture of degarelix
#106COMBINATORIAL ANDROGEN DEPRIVATION WITH AN ANDROGEN RECEPTOR VACCINE
#107LHRH-PACLITAXEL CONJUGATES AND METHODS OF USE
#108LHRH-CONJUGATED PRODIGIOSIN AND USES THEREOF
#109Method of treating prostate cancer with GnRH antagonist
#110Gonadotropin-releasing hormones for use as adjuvant immunotherapeutics
#111Method for preparing biodegradable microspheres using stabilized single-phase mixed solution
#112Manufacture of Degarelix
#113Methods and compositions for treatment of penile defects
#114Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device
#115Liquid polymer delivery system for extended administration of drugs
#116Composition for treating one or more estrogen related diseases
#117METHODS OF TREATING CANCER WITH ANDROGEN DEPRIVATION THERAPY IN COMBINATION WITH AN INHIBITOR OF THE SP1 TRANSCRIPTION FACTOR
#118Vaginal systemic drug delivery
#119TREATMENT WITH ANTI-VEGF ANTIBODIES
#120METHOD AND KIT FOR HOME CONTROLLED OVARIAN STIMULATION FOR IN VITRO FERTILIZATION
#121System and method for diagnosis and treatment
#122METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS
#123Pharmaceutical compositions and related methods of delivery
#124Pharmaceutical compositions having a selected release duration
#125CONTROLLED-RELEASE FORMULATIONS
#126METHOD AND KIT FOR HOME CONTROLLED OVARIAN STIMULATION FOR IN VITRO FERTILIZATION
#127Method and kit for home controlled ovarian stimulation for in vitro fertilization
#128METHOD AND COMPOSITION FOR SYNCHRONIZING TIME OF INSEMINATON
#129Method of Treating a Child with Central Precocious Puberty using an Extended Release Composition
#130COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS
#131Long-acting palmitic acid-conjugated GnRH derivative, and pharmaceutical composition containing same
#132Methods of treating prostate cancer with GnRH antagonist
#133Method for preparing micro-particles by double emulsion technique
#134Medicine for combined use in cancer treatment
#135METHODS AND COMPOSITIONS FOR DETECTING AND TREATING ENDOMETRIOSIS
#136COMPOSITIONS AND METHODS FOR TREATING PRECOCIOUS PUBERTY
#137TREATMENT WITH ANTI-VEGF ANTIBODIES
#138Gonadotropin-releasing hormone antagonist dosing regimens for the treatment of endometriosis
#139COMPOSITION FOR TREATING ACUTE URINARY RETENTION
#140COMPOSITION FOR ENHANCING SENSITIVITY OF PROSTATE CANCER TO ANTICANCER DRUG AND USE THEREOF
#141METHODS FOR ASSESSING THE PROBABILITY OF ACHIEVING ONGOING PREGNANCY AND INFORMING TREATMENT THEREFROM
#142A COMPOSITION COMPRISING AT LEAST ONE GNRH ANTAGONIST
#143Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device
#144Immunorhelin compounds for intracellular infections
#145PREPARATION OF MICROPARTICLES OF AN ACTIVE INGREDIENT
#146Use of known compounds—intracellular infections
#147Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof
#148Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases
#149TRIPARTITE COMBINATION THERAPY FOR PROSTATE CANCER
#150Compositions and methods for immune cell modulation in adoptive immunotherapies
#151Syringe-connector device for the separate administration of controlled quantities at least two products in a single injection
#152Pharmaceutical compositions with enhanced stability
#153Manufacture of Degarelix
#154METHOD OF PRODUCING LEUPROLIDE MICROSPHERE AND USE
#155Process for the synchronization of ovulation for timed breeding without heat detection
#156ACTIVE SELF-HEALING BIOMATERIAL SYSTEM
#157METHODS FOR TREATING METASTATIC STAGE PROSTATE CANCER
#158System and method for diagnosis and treatment
#159Method of treatment of breast or colon cancer by administering muscle stimulated myokines
#160Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
#161Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device
#162PREPARATION METHOD OF SUSTAINED-RELEASE MICROPARTICLES
#163Recovery and processing of human embryos formed in vivo
#164Injectable composition for delivery of a biologically active agent
#165Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (VSELs)
#166Amniotic fluid composition and method of using
#167Vented cover plate for an array of syringes
#168PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#169Selective progesterone receptor modulators (SPRM) and stabilized estrogen level in patient
#170Increasing cancer patient survival time by administration of dithio-containing compounds
#171System and method for diagnosis and treatment
#172System and Method for Diagnosis and Treatment
#173Treatment of prostate carcinoma
#174Formulations and methods for controlling the reproductive cycle and ovulation
#175Recovery and processing of human embryos formed in vivo
#176COMPOSITIONS AND METHODS FOR TREATING PRECOCIOUS PUBERTY
#177COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS
#178Methods of preparing stimuli-responsive multifunctional nanoparticles
#179COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS
#180COMBINATION ADMINISTRATION OF GNRH ANTAGONISTS
#181Liquid polymer delivery system for extended administration of drugs
#182THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#183WOUND HEALING USING TOPICAL SYSTEMS AND METHODS
#184Method and composition for synchronizing time of insemination
#185Method and compositions for synchronizing time of insemination in gilts
#186Sustained release polymer
#187NOVEL TREATMENT OF PROSTATE CARCINOMA
#188Method of Modulating the Concentration of Proteins in Cerebrospinal Fluid
#189BRAIN AND NEURAL TREATMENTS COMPRISING PEPTIDES AND OTHER COMPOSITIONS
#190Methods of making pharmaceutical compositions with enhanced stability
#191Solid Oral Dosage Forms
#192Pharmaceutical compositions of goserelin sustained release microspheres
#193Recovery and processing of human embryos formed in vivo
#194CONTROLLED-RELEASE FORMULATIONS
#195PEPTIDE SYSTEMS AND METHODS FOR METABOLIC CONDITIONS
#196Sustained release polymer
#197Compositions and methods for detection of hepatitis C virus genotype 3
#198Combinatorial androgen deprivation with an androgen receptor vaccine
#199SOLVENT/POLYMER SOLUTIONS AS SUSPENSION VEHICLES
#200Wound healing using topical systems and methods
#201COMPOSITIONS AND METHODS FOR TREATING PITUITARY TUMORS
#202Pharmaceutical combinations
#203Method of treating bone metastasis diseases, medicaments therefore, and a method of predicting the clinical outcome of treating bone metastasis diseases
#204Methods of treating prostate cancer with GnRH antagonist
#205Cancer treatment combination compositions, methods and uses
#206Methods, agents and compositions for treatment of inflammatory conditions
#207Treatment of prostate carcinoma
#208Leuprolide injection
#209Brain and neural treatments comprising peptides and other compositions
#210Peptide systems and methods for metabolic conditions
#211Systems and methods for delivery of peptides
#212Cardiovascular disease treatment and prevention
#213Pharmaceutical composition containing leuprolide and having both immediate and sustained release properties
#214INTRAVAGINAL FORMULATIONS COMPRISING GnRH
#215Method for treating chemotherapy-induced male infertility
#216COMPOSITIONS AND METHODS FOR TREATING PRECOCIOUS PUBERTY
#217Pharmaceutical compositions with enhanced stability
#218NOVEL SUSTAINED RELEASE POLYMER
#219Methods and compositions for managing reproduction
#220METHODS FOR SYNCHRONIZATION OF ESTROUS CYCLES AND OVULATION FOR FIXED TIME ARTIFICIAL INSEMINATION IN CATTLE
#221Stable formulations for parenteral injection of peptide drugs
#222CONTROLLED OVARIAN HYPERSTIMULATION WITH IMPROVED RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE
#223Method of manufacture of GnRH-containing gel
#224Method of treating prostate cancer with GnRH antagonist
#225Short interfering RNA (siRNA) analogues
#226METHOD AND COMPOSITION FOR SYNCHRONIZING TIME OF INSEMINATION IN GILTS
#227IMMUNE MODULATION USING PEPTIDES AND OTHER COMPOSITIONS
#228Pharmaceutical compositions with enhanced stability
#229Pharmaceutical Combinations
#230Process for the synchronization of ovulation for timed breeding without heat detection
#231Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
#232Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
#233Wound healing using topical systems and methods
#234Increasing cancer patient survival time by administration of dithio-containing compounds
#235System and method for diagnosis and treatment
#236System and method for diagnosis and treatment
#237Method and composition for synchronizing time of insemination
#238Microparticles comprising GNRH made by PGSS
#239Sustained release polymer
#240ANDROGEN RECEPTOR MODULATOR AND USES THEREOF
#241Cardiovascular disease treatment and prevention
#242Peptides for enhancing transdermal delivery
#243Solid oral dosage forms
#244COMPOSITIONS AND METHODS FOR TREATING PRECOCIOUS PUBERTY
#245AQUEOUS SUSTAINED RELEASE COMPOSITIONS OF LHRH ANALOGUES
#246Method for delivering gonadotropin releasing hormone into a lumen of the intestinal tract
#247Pharmaceutical compositions and related methods of delivery
#248Injectable delivery of microparticles and compositions therefor
#249POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY
#250Pharmaceutical composition with improved stability
#251TREATMENT OF AGING EFFECTS BY GONADOTROPIN-RELEASING HORMONE, NEUROGENESIS OR BRAIN IKK BETA/NF-KAPPAB INHIBITION
#252PHARMACEUTICAL COMPOSTIONS COMPRISING KISSPEPTIN OR DERIVATIVES THEREOF
#253Cyclodextrin-Based Polymers for Therapeutic Delivery
#254PHARMACEUTICAL COMPOSITIONS OF GOSERELIN SUSTAINED RELEASE MICROSPHERES
#255IMPLANTABLE DRUG DELIVERY COMPOSITIONS COMPRISING NON-POLYMERIC SORPTION ENHANCERS AND METHODS OF TREATMENT THEREOF
#256Treatment of prostate carcinoma
#257Recovery and processing of human embryos formed in vivo
#258Recovery and processing of human embryos formed in vivo
#259Recovery and processing of human embryos formed in vivo
#260Particulate drug delivery methods
#261Method and compositions for synchronizing time of insemination in gilts
#262Sustained-release lipid pre-concentrate of GNRH analogues and pharmaceutical composition comprising the same
#263Diagnosis and treatment of endometriosis and related conditions
#264Solvent/polymer solutions as suspension vehicles
#265Hormone Normalization Therapy and Uses Therefor
#266Use of degarelix in the treatment of endometriosis and related diseases
#267RECOVERY AND PROCESSING OF HUMAN EMBRYOS FORMED IN VIVO
#268Methods and compositions for determining resistance to androgen receptor therapy
#269Compositions of GnRH related compounds and processes of preparation
#270Methods of treating rheumatoid arthritis
#271Systems and methods for delivery of peptides
#272Peptide systems and methods for metabolic conditions
#273Treatment of skin, including aging skin, to improve appearance
#274Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogen
#275Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
#276POLYMERIC DELIVERY FORMULATIONS OF LEUPROLIDE WITH IMPROVED EFFICACY
#277Active self-healing biomaterial system
#278LONG TERM DRUG DELIVERY DEVICES WITH POLYURETHANE-BASED POLYMERS AND THEIR MANUFACTURE
#279Process for the synchronization of ovulation for timed breeding without heat detection
#280APPLICATION OF INITIAL DOSES OF LHRH ANALOGUES AND MAINTENANCE DOSES OF LHRH ANTAGONISTS FOR THE TREATMENT OF HORMONE-DEPENDENT CANCERS AND CORRESPONDING PHARMACEUTICAL KITS
#281Method and composition for synchronizing time of insemination
#282Vaginal Drug Delivery Devices and Manufacturing Methods
#283SUSTAINED RELEASE FORMULATIONS COMPRISING GNRH ANALOGUES
#284COMPOSITIONS AND METHODS FOR TREATING PRECOCIOUS PUBERTY
#285Methods for treating metastatic stage prostate cancer
#286Robust controlled-release formulations
#287Polymeric Devices for Controlled Release of Active Agents
#288PHARMACEUTICAL COMPOSITION
#289Robust controlled-release peptide formulations
#290Method of preparing microspheres by using polymer having sol-gel transition property and microspheres prepared thereby
#291BRAIN AND NEURAL TREATMENTS COMPRISING PEPTIDES AND OTHER COMPOSITIONS
#292Methods and systems for treating or preventing cancer
#293Peptide systems and methods for metabolic conditions
#294Wound healing using topical systems and methods
#295CARDIOVASCULAR DISEASE TREATMENT AND PREVENTION
#296Short interfering RNA (siRNA) analogues
#297Method for treating chemotherapy-induced male infertility
#298Androgen receptor modulator and uses thereof
#299Stable formulations for parenteral injection of peptide drugs
#300Stable formulations for parenteral injection of peptide drugs